Ohtsuka T, Kubota A, Hirano T, Watanabe K, Yoshida H, Tsurufuji M, Iizuka Y, Konishi K, Tsurufuji S
Institute of Cytosignal Research, Inc., Tokyo, Japan.
J Biol Chem. 1996 Jan 19;271(3):1651-9. doi: 10.1074/jbc.271.3.1651.
The glucocorticoid dexamethasone inhibited the production of the rat cytokine-induced neutrophil chemoattractant CINC/gro, a counterpart of human melanoma growth-stimulating activity that belongs to the interleukin-8 (IL-8) family, in the normal rat kidney epithelial cell line NRK-52E stimulated with interleukin-1 beta (IL-1 beta), lipopolysaccharide, or tumor necrosis factor alpha. The accumulation of CINC/gro mRNA induced by these activators was also decreased comparably by dexamethasone. A nuclear run-on assay revealed that dexamethasone decreased the IL-1 beta-induced transcription of the CINC/gro gene. The half-life of CINC/gro mRNA transcripts did not change significantly after exposure to dexamethasone, suggesting that this glucocorticoid acts mainly at the transcriptional level. Transfection with luciferase expression vectors containing 5'-deleted and mutated CINC/gro gene sequences demonstrated that the 5'-flanking region containing the NF-kappa B binding site is involved in the IL-1 beta- and dexamethasone-induced activation and repression of the CINC/gro gene expression, respectively. Furthermore, a tandem repeat of the NF-kappa B sequence in the CINC/gro gene conferred the inducibility by IL-1 beta and suppression of luciferase activity by dexamethasone. In an electrophoretic mobility shift assay, dexamethasone diminished the IL-1 beta-induced formation of NF-kappa B complexes, which consisted of p65 and p50. Western blotting revealed that dexamethasone inhibited the IL-1 beta-induced translocation of p65 from the cytoplasm into the nucleus, while the nuclear level of NF-kappa B p50 remained almost unchanged. In addition, the degradation of I kappa B-alpha induced by IL-1 beta was not inhibited by dexamethasone. These results indicated that the suppression of the CINC/gro gene transcription by glucocorticoid occurs through the impairment of NF-kappa B activation, possibly by interference with the translocation of NF-kappa B p65 from the cytoplasm into the nucleus, thereby suppressing transactivation of the CINC/gro gene.
糖皮质激素地塞米松在白细胞介素 -1β(IL -1β)、脂多糖或肿瘤坏死因子α刺激的正常大鼠肾上皮细胞系NRK - 52E中,抑制大鼠细胞因子诱导的中性粒细胞趋化因子CINC/gro的产生,CINC/gro是人类黑素瘤生长刺激活性的对应物,属于白细胞介素 -8(IL -8)家族。地塞米松同样降低了这些激活剂诱导的CINC/gro mRNA的积累。核转录实验表明,地塞米松降低了IL -1β诱导的CINC/gro基因的转录。暴露于地塞米松后,CINC/gro mRNA转录本的半衰期没有显著变化,这表明这种糖皮质激素主要在转录水平发挥作用。用含有5' - 缺失和突变的CINC/gro基因序列的荧光素酶表达载体进行转染表明,含有NF -κB结合位点的5' - 侧翼区域分别参与IL -1β和地塞米松诱导的CINC/gro基因表达的激活和抑制。此外,CINC/gro基因中NF -κB序列的串联重复赋予了IL -1β诱导性和地塞米松对荧光素酶活性抑制作用。在电泳迁移率变动分析中,地塞米松减少了IL -φ诱导的由p65和p50组成的NF -κB复合物的形成。蛋白质免疫印迹显示,地塞米松抑制了IL -1β诱导的p65从细胞质向细胞核的转位,而NF -κB p50的核水平几乎保持不变。此外,地塞米松不抑制IL -1β诱导的IκB -α的降解。这些结果表明,糖皮质激素对CINC/gro基因转录的抑制是通过损害NF -κB激活而发生的,可能是通过干扰NF -κB p65从细胞质向细胞核的转位,从而抑制CINC/gro基因的反式激活。